phenylephrine

ARC 239 dihydrochloride 是一种选择性 α2B 肾上腺素受体拮抗剂。

Phenylephrine ((R)-(-)-Phenylephrine) 是一种选择性的α1-肾上腺素受体激动剂，常用作减充血剂。

DL-Phenylephrine HCl is a selective agonist of the alpha1-adrenergic receptor.

Phenylephrine-3-O-sulfate is metabolite of the α1A-adrenergic receptor agonist phenylephrine formed via sulfation.

L-Phenylephrine is an alpha-adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent.

Phenylephrine glucuronide, a metabolite of phenylephrine (an α1A-adrenergic receptor agonist), is produced through metabolic processes.

Phenylephrine hydrochloride (NCI-c55641) 是选择性的α1-肾上腺素能受体激动剂，对α1A，α1B 和α1D 受体的pKis 分为4.70，4.87和5.86。

(R)-(-)-Phenylephrine-2,4,6-d3 是 (R)-(-)-Phenylephrine 的氘代化合物。(R)-(-)-Phenylephrine 的 CAS 号为 59-42-7。Phenylephrine 是一种选择性的α1-肾上腺素受体激动剂，常用作减充血剂。

Etilefrine hydrochloride 是一种去氧肾上腺素相关的 β-1 肾上腺素和 α 肾上腺素激动剂，用作强心剂和抗低血压剂。

Norfenefrine HCl（盐酸去甲苯福林）是一种 α1-adrenergic受体激动剂，是一种内源性的神经递质，是治疗低血压的拟交感神经药物，引起平滑肌收缩和血管收缩导致血压升高，还能够提高脂肪组织中的甘油水平。

Siguazodan (SKF 94836) 是选择性的，口服有效的磷酸二酯酶 III 抑制剂，IC50为 117 nM。它可增加完整血小板中 cAMP 的积累，EC50为 18.88 μM。它也抑制苯肾上腺素诱导的 5-HT 释放，IC50为 4.2 μM。

Talibegron hydrochloride (ZD2079 hydrochloride) 是一种β3肾上腺素能受体激动剂，对苯肾上腺素预收缩大鼠肠系膜动脉的 pD2为3.72。松弛大鼠肠系膜动脉和离体主动脉。在体内抑制瘦小鼠 ob 基因表达和循环瘦素水平。

Iroxanadine (BRX-005) 是一种新型小分子MAPK p38 抑制剂，诱导p38 SAPK 的磷酸化，在用去氧肾上腺素预先收缩的豚鼠肺动脉制剂中诱导浓度依赖性松弛，可用于治疗动脉粥样硬化、糖尿病血管病，微血管心绞痛和外周动脉疾病等血管疾病。

Danshensu sodium salt (Sodium Danshensu) 是从中国草本丹参中提取的一种天然产物，可以抑制去氧肾上腺素和CaCl2 在无Ca2+ 培养基中引起的血管收缩。

p-Hydroxymandelic acid (4-Hydroxymandelic acid) 是有价值的芳香类化学品，常用于生产药物和食品添加剂。

Ethyl cinnamate 是食品香料和化妆品添加剂，也是哺乳动物组织的优良清除剂。

Harmalol hydrochloride (Harmidol hydrochloride) 是一种可从Peganum harmala L.的种子中提取出来的β-咔啉生物碱。Harmalol hydrochloride 是Harmaline 的主要代谢产物，在转录和翻译后水平上显著抑制二恶英介导的 CYP1A1 诱导。Harmalol hydrochloride 在去氧肾上腺素或KCl 预先收缩的分离大鼠胸主动脉制剂中显示出血管松弛活性。 Harmalol hydrochloride 具有抗氧化活性.

α2AR agonist 1 (compound S6a) 是一种含有吗啉嘧啶酮的化合物，作为 α2-肾上腺素受体 (α2AR) 的激动剂。该化合物在主动脉环经苯肾上腺素 (pEC50=6.81) 预收缩后，会引发浓度依赖性的舒张反应。此外，α2AR agonist 1 还能提升 HUVEC 中的 NOx 和 NO 水平。

DHP-218 is a calcium channel antagonist. DHP-218 inhibits Calcium-induced contraction of the rat aorta in high K+ solution with the pA2 value of 9.11. The IC50 value for the inhibitory effects of DHP-218 in high K+-induced and phenylephrine-induced contra

Berefrine is an Oxazolidine prodrug of phenylephrine.

S-Nitrosothiols (RSNOs) are a class of molecules that function as exogenous and endogenous nitric oxide (NO) donors. RSNOs found in vivo include proteins such as S-nitrosohemoglobin and S-nitrosoalbumin, as well as low molecular weight species such as S-nitrosoglutathione (GSNO) and S-nitrosocysteine (CysNO). CAY10563 is a member of a new class of S-nitrosothiol species that act as an NO donors under acidic conditions. It decomposes with a half-life of one minute in 0.1 M phosphate buffer, pH 5.0, at 37°C and relaxes phenylephrine-constricted rat aortic strips 59% and 16% at pH 6.0 and 7.4, respectively.

S-Nitrosothiols (RSNOs) are a class of molecules that function as exogenous and endogenous nitric oxide (NO) donors. RSNOs found in vivo include proteins such as S-nitrosohemoglobin and S-nitrosoalbumin, as well as low molecular weight species such as S-nitrosoglutathione (GSNO) and S-nitrosocysteine (CysNO). CAY10564 is a member of a new class of S-nitrosothiol species that act as NO donors under acidic conditions. It decomposes with a half-life of one minute in 0.1 M phosphate buffer, pH 5.0, at 37°C and relaxes phenylephrine-constricted rat aortic strips 59% and 16% at pH 6.0 and 7.4, respectively.

S-Nitrosothiols (RSNOs) are a class of molecules that function as exogenous and endogenous nitric oxide (NO) donors. RSNOs found in vivo include proteins such as S-nitrosohemoglobin and S-nitrosoalbumin, as well as low molecular weight species such as S-nitrosoglutathione (GSNO) and S-nitrosocysteine (CysNO). CAY10565 is a member of a new class of S-nitrosothiol species that act as NO donors under acidic conditions. It decomposes with a half-life of 130 minutes in 0.1 M phosphate buffer, pH 5.0, at 37°C and relaxes phenylephrine-constricted rat aortic strips 71% and 44% at pH 6.0 and 7.4, respectively.

5(6)-EET is a fully racemic version of the enantiomeric forms biosynthesized from arachidonic acid by cytochrome P450 enzymes. In solution, 5(6)-EET degrades into 5,6-DiHET and 5(6)-δ-lactone, which can be converted to 5(6)-DiHET and quantified by GC-MS. In neuroendocrine cells, such as the anterior pituitary and pancreatic islets, 5(6)-EET has been implicated in the mobilization of calcium and hormone secretion. 5(6)-EET is an inhibitor of T-type voltage-gated calcium channels (Cav3) that inhibits isoforms Cav3.1, Cav3.2 (IC50 = 0.54 μM), and Cav3.3 and decreases nifedipine-resistant phenylephrine-induced vasoconstriction in isolated mouse mesenteric arteries via Cav3.2 blockade when used at a concentration of 3 μM. In addition, it is a substrate of COX-1 and COX-2, as measured by oxygen consumption and product formation assays when used at a concentration of 50 μM. (±)5(6)-EET is provided as a mixture of the free acid and lactone.